US Stock MarketDetailed Quotes

GNFT Genfit

Watchlist
  • 4.133
  • -0.067-1.59%
Close Feb 14 16:00 ET
206.28MMarket Cap10.68P/E (TTM)

About Genfit Company

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-Fran?ois Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.

Company Profile

SymbolGNFT
Company NameGenfit
Listing DateMar 27, 2019
Issue Price20.32
Founded1999
CEOMr. Pascal Prigent
MarketNASDAQ
Employees159
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressParc Eurasante,885, Avenue Eugène Avinée,Lille Métropole
CityLoos
ProvinceHF
CountryFrance
Zip Code59120
Phone33-3-20-16-40-00

Company Executives

  • Name
  • Position
  • Salary
  • Pascal Prigent
  • Chief Executive Officer
  • --
  • Jean-Christophe Marcoux
  • Chief Corporate Affairs Officer, Head of Investor Relations and Head of ESG
  • --
  • Carol Addy
  • Chief Medical Officer
  • --
  • Pascal Caisey
  • Chief Operating Officer
  • --
  • Dr. Meriam Kabbaj, PhD
  • Chief Technology Officer
  • --
  • Thomas Baetz
  • Chief Financial Officer
  • --
  • Stefanie Magner
  • Chief Compliance Officer and Executive Vice President, International Legal Affairs
  • --
  • Dean Hum, PhD
  • Chief Scientific Officer
  • --
  • John Brozek
  • Executive Vice President, Data and Information Technology
  • --
  • Sayah-Jeanne Sakina
  • Executive Vice President, Research and Translational Science
  • --
  • Tom Huijbers
  • Executive Vice President, Regulatory
  • --
  • Emilie Desodt
  • Executive Vice President, Human Resources
  • --
  • Xavier Guille des Buttes
  • Vice Chairman of the Board
  • --
  • Jean-Francois Mouney
  • Chairman of the Board
  • --
  • Laurent Lannoo
  • Corporate Secretary and Director of Legal Affairs
  • --
  • Sandra Silvestri
  • Director
  • --
  • Florence Sejourne
  • Director
  • --
  • Eric Baclet
  • Independent Director
  • --
  • Anne-Helene Monsellato
  • Independent Director
  • --
  • Dr. Catherine Larue, PhD
  • Independent Director
  • --
  • Katherine Bach Kalin, M.B.A.
  • Independent Director
  • --
  • Jean-Francois Tine
  • Independent Director
  • --
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.